Libtayo

Active substance

Cemiplimab

Holder

Sanofi

Status

Closed

Indication

Treatment of patients with metastatic or locally advanced cutaneous squamous cell carcinoma who are not candidates for curative surgery or curative radiation.

Public documents

Approbation

Information for the patient

Informed consent

Last update

01/04/2021